Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz J, Lane HC, Muyembe-Tamfum JJ; PALM Writing Group; Sivahera B, Camara M, Kojan R, Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y, Tierney J, Sivapalasingam S, Holman W, Gettinger N, Vallée D, Nordwall J; PALM Consortium Study Team. Mulangu S, et al. N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27. N Engl J Med. 2019. PMID: 31774950 Free PMC article. Clinical Trial.
Rhabdomyolysis, acute kidney injury, and mortality in Ebola virus disease: retrospective analysis of cases from Eastern Democratic Republic of the Congo, 2019.
Masumbuko Claude K, Mukadi-Bamuleka D, Kitenge-Omasumbu R, Edidi-Atani F, Kuamfumu MM, Mulangu S, Tshiani-Mbaya O, Malengera Vicky K, Mbala-Kingebeni P, Ahuka-Mundeke S, Muyembe-Tamfum JJ, Lee BE, Houston S, Mumtaz Z, Hawkes MT. Masumbuko Claude K, et al. Among authors: mulangu s. J Infect Dis. 2024 May 2:jiae224. doi: 10.1093/infdis/jiae224. Online ahead of print. J Infect Dis. 2024. PMID: 38696335
Cost-effectiveness of incorporating Ebola prediction score tools and rapid diagnostic tests into a screening algorithm: A decision analytic model.
Tshomba AO, Mukadi-Bamuleka D, De Weggheleire A, Tshiani OM, Kayembe CT, Mbala-Kingebeni P, Muyembe-Tamfum JJ, Ahuka-Mundeke S, Chenge FM, Jacobs BKM, Mumba DN, Tshala-Katumbay DD, Mulangu S. Tshomba AO, et al. Among authors: mulangu s. PLoS One. 2023 Oct 17;18(10):e0293077. doi: 10.1371/journal.pone.0293077. eCollection 2023. PLoS One. 2023. PMID: 37847703 Free PMC article.
The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries.
Nachega JB, Mbala-Kingebeni P, Rosenthal PJ, Rimoin AW, Hoff NA, Liesenborghs L, Vanlerberghe V, Andrei G, Rawat A, Wilson LA, Forrest J, Mills EJ, Hermans MP, Mulangu S, Ntoumi F, Zumla A, Muyembe-Tamfum JJ. Nachega JB, et al. Among authors: mulangu s. Am J Trop Med Hyg. 2023 Aug 14;109(4):719-724. doi: 10.4269/ajtmh.23-0161. Print 2023 Oct 4. Am J Trop Med Hyg. 2023. PMID: 37580027
Development of Ebola virus disease prediction scores: Screening tools for Ebola suspects at the triage-point during an outbreak.
Tshomba AO, Mukadi-Bamuleka DR, De Weggheleire A, Tshiani OM, Kitenge RO, Kayembe CT, Jacobs BKM, Lynen L, Mbala-Kingebeni P, Muyembe-Tamfum JJ, Ahuka-Mundeke S, Mumba DN, Tshala-Katumbay DD, Mulangu S. Tshomba AO, et al. Among authors: mulangu s. PLoS One. 2022 Dec 16;17(12):e0278678. doi: 10.1371/journal.pone.0278678. eCollection 2022. PLoS One. 2022. PMID: 36525443 Free PMC article.
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection.
Bluemling GR, Mao S, Natchus MG, Painter W, Mulangu S, Lockwood M, De La Rosa A, Brasel T, Comer JE, Freiberg AN, Kolykhalov AA, Painter GR. Bluemling GR, et al. Among authors: mulangu s. Antiviral Res. 2023 Jan;209:105453. doi: 10.1016/j.antiviral.2022.105453. Epub 2022 Nov 13. Antiviral Res. 2023. PMID: 36379378 Free article.
Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo.
Jaspard M, Mulangu S, Juchet S, Serra B, Dicko I, Lang HJ, Baka BM, Komanda GM, Katsavara JM, Kabuni P, Mambu FM, Isnard M, Vanhecke C, Letord A, Dieye I, Patterson-Lomba O, Mbaya OT, Isekusu F, Mangala D, Biampata JL, Kitenge R, Kinda M, Anglaret X, Muyembe JJ, Kojan R, Ezzedine K, Malvy D. Jaspard M, et al. Among authors: mulangu s. EClinicalMedicine. 2022 Oct 13;54:101699. doi: 10.1016/j.eclinm.2022.101699. eCollection 2022 Dec. EClinicalMedicine. 2022. PMID: 36263398 Free PMC article.
Virus kinetics and biochemical derangements among children with Ebolavirus disease.
Kjaldgaard L, Claude KM, Mukadi-Bamuleka D, Kitenge-Omasumbu R, Dixit D, Edidi-Atani F, Kuamfumu MM, Bulabula-Penge J, Mambu-Mbika F, Tshiani-Mbaya O, Diaz J, Mulangu S, Legand A, Mbala-Kingebeni P, Formenty P, Ahuka-Mundeke S, Muyembe-Tamfum JJ, Hawkes MT. Kjaldgaard L, et al. Among authors: mulangu s. EClinicalMedicine. 2022 Sep 5;53:101638. doi: 10.1016/j.eclinm.2022.101638. eCollection 2022 Nov. EClinicalMedicine. 2022. PMID: 36105872 Free PMC article.
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.
Longini IM, Yang Y, Fleming TR, Muñoz-Fontela C, Wang R, Ellenberg SS, Qian G, Halloran ME, Nason M, Gruttola V, Mulangu S, Huang Y, Donnelly CA, Henao Restrepo AM. Longini IM, et al. Among authors: mulangu s. Clin Trials. 2022 Dec;19(6):647-654. doi: 10.1177/17407745221110880. Epub 2022 Jul 22. Clin Trials. 2022. PMID: 35866633 Free PMC article. Clinical Trial.
36 results